Home

Bioworkshops sell "Guselkumab"

Basic Information

1.1K
87
8
4.7(55)

Trade Type

Sell

Product Name

Guselkumab

Manufacturer(s)

Specifications

  • Application: Biosimilar cell line targeting IL-23p19, the mechanism of action of the reference monoclonal antibody approved in the US (2017) for plaque psoriasis and other immune, digestive, skin and musculoskeletal conditions
  • Certification Standard: Developed from a cell line with DMF filing for global regulatory readiness and streamlined submissions
  • Regulatory Status: Proven analytical comparability to the reference product, supporting regulatory and clinical acceptance

Documents

GMP
Filters:
Sort by:

    No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product